Ministry Devises Policy To Improve Information-gathering On Immunization Side Effects
This article was originally published in PharmAsia News
Japan’s Ministry of Health, Labor, and Welfare, together with the National Institute of Infectious Diseases (Tokyo) and the Pharmaceuticals and Medicals Devices Agency, has decided on a policy to strengthen information gathering regarding side effects such as shock, paralysis, and fever occurring after vaccinations, and will devise a centrally managed database next year to store the information.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.